Moreover, downregulation of GRP94 in prostate cancer cells can cause upregulation of cleaved caspase-9 and Bax expression levels, while suppression of Bcl-2 and Vimentin expression levels can induce apoptosis and inhibition of prostate cancer cell invasion [42]. Here, BCL2 is linked to prostate carcinoma.